N-(4-(5-(3-Morpholinopropyl)-2,3,4,5-tetrahydro-1H-benzo[b](1,4)diazepine-1-carbonyl)phenyl)nicotinamide

ID: ALA5189594

PubChem CID: 168282434

Max Phase: Preclinical

Molecular Formula: C29H33N5O3

Molecular Weight: 499.62

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccc(C(=O)N2CCCN(CCCN3CCOCC3)c3ccccc32)cc1)c1cccnc1

Standard InChI:  InChI=1S/C29H33N5O3/c35-28(24-6-3-13-30-22-24)31-25-11-9-23(10-12-25)29(36)34-17-5-16-33(26-7-1-2-8-27(26)34)15-4-14-32-18-20-37-21-19-32/h1-3,6-13,22H,4-5,14-21H2,(H,31,35)

Standard InChI Key:  SPGMPSQDDYQCPP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   -3.5482    0.7304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5482   -0.0945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8337   -0.5070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1191   -0.0945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4740   -0.6088    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6576   -1.4133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4460   -1.6566    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0528   -1.9745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2363   -2.7790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6315   -3.3402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1568   -3.0969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7615   -3.6581    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5500   -3.4150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7337   -2.6105    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1549   -3.9761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9713   -4.7805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5762   -5.3418    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3646   -5.0986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5482   -4.2942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9433   -3.7329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3403   -2.2925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2643   -1.7313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6695   -0.4253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3116    0.3179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6695    1.0614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4740    1.2449    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6576    2.0493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0528    2.6105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2363    3.4150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6315    3.9762    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1568    3.7329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7615    4.2942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5780    5.0986    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2103    5.3418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8150    4.7806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1191    0.7304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8337    1.1430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 20 15  2  0
 19 20  1  0
 11 21  2  0
 21 22  1  0
 22  8  2  0
  5 23  1  0
 24 23  1  0
 25 24  1  0
 26 25  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 30  1  0
 36 26  1  0
  4 36  2  0
 36 37  1  0
 37  1  2  0
M  END

Alternative Forms

  1. Parent:

    ALA5189594

    ---

Associated Targets(Human)

AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 499.62Molecular Weight (Monoisotopic): 499.2583AlogP: 3.91#Rotatable Bonds: 7
Polar Surface Area: 78.01Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.11CX LogP: 2.66CX LogD: 2.48
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.53Np Likeness Score: -1.70

References

1. Cao X, Wang P, Yuan H, Zhang H, He Y, Fu K, Fang Q, Liu H, Su L, Yin L, Xu P, Xie Y, Xiong X, Wang J, Zhu X, Guo D..  (2022)  Benzodiazepine Derivatives as Potent Vasopressin V2 Receptor Antagonists for the Treatment of Autosomal Dominant Kidney Disease.,  65  (13.0): [PMID:35579344] [10.1021/acs.jmedchem.2c00567]

Source